Ciprofloxacin in preterm neonates: case report and review of the literature

被引：0

作者：

H. L. A. van den Oever

F. G. A. Versteegh

E. A. P. M. Thewessen

J. N. van den Anker

J. W. Mouton

H. J. Neijens

机构：

[1] Department of Paediatrics,

[2] Groene Hart Hospital,undefined

[3] P.O. Box 1098,undefined

[4] 2800 BB Gouda,undefined

[5] The Netherlands,undefined

[6] Tel.: +31-182-566 666,undefined

[7] Fax: +31-182-521 746,undefined

[8] Department of Microbiology,undefined

[9] Groene Hart Hospital,undefined

[10] Gouda,undefined

[11] The Netherlands,undefined

[12] Department of Paediatrics,undefined

[13] Sophia Children's Hospital,undefined

[14] Rotterdam,undefined

[15] The Netherlands,undefined

[16] Department of Clinical Microbiology,undefined

[17] Sophia Children's Hospital,undefined

[18] Rotterdam,undefined

[19] The Netherlands,undefined

来源：

European Journal of Pediatrics | 1998年 / 157卷

关键词：

Key words Ciprofloxacin; Paediatric; Preterm neonates; Pharmacology; Side-effects;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We report the use of ciprofloxacin in a preterm boy suffering from an invasive multiple resistant Enterobacter cloacae infection. The treatment was effective, after other antibiotics failed, and no adverse effects were observed during 3 years of follow up. The literature on compassionate ciprofloxacin use in 28 preterm or low birth weight infants is reviewed. Ciprofloxacin has been used to treat neonatal pneumonia, meningitis and septicaemia and was effective in all cases. Side-effects were limited to dental dyschromia and one observation on the emergence of resistance. Pharmacokinetics of ciprofloxacin were studied in seven preterm infants; iv doses ranging from 4 to 40 mg/kg per day revealed adequate serum peak concentrations (0.98–5.7 mg/l) but trough-peak ratios were high (median ratio: 32%), suggesting slower elimination in preterm infants as compared to older children. CSF concentrations were 0.10–1.45 mg/l.

引用

页码：843 / 845

页数：2